Vaccinex, Inc.
VCNX
$0.72
-$0.02-2.70%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.72% | -16.69% | 20.24% | 21.46% | 34.68% |
| Total Depreciation and Amortization | -37.04% | -22.58% | -13.33% | -12.90% | -40.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 103.67% | 989.57% | -70.63% | -960.47% | -1,565.91% |
| Change in Net Operating Assets | 74.28% | -25.31% | -17.47% | 246.22% | -931.79% |
| Cash from Operations | 49.18% | -3.62% | 19.83% | 8.10% | -68.23% |
| Capital Expenditure | -- | 55.56% | -- | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 55.56% | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.88% | -68.42% | 63.16% | 0.00% | 10.53% |
| Issuance of Common Stock | 69.17% | -100.00% | -100.00% | 143.87% | 24.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -234.82% | -- | -- | -- | -- |
| Cash from Financing | -76.68% | 342.04% | -58.70% | 200.30% | 140.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -227.77% | 250.08% | -93.57% | 146.84% | 277.11% |